HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

trans-dihydrolycoricidine

structure in first source

Also Known As:

R430 compound

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Ethylamines: 5
    - Phenethylamines: 28
      - Amaryllidaceae Alkaloids: 33
        trans-dihydrolycoricidine: 2
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Amaryllidaceae Alkaloids: 33
    - trans-dihydrolycoricidine: 2

Experts

1.	Hegedűs, László: 1 article (07/2019)
2.	Kádas, István: 1 article (07/2019)
3.	Pogrányi, Balázs: 1 article (07/2019)
4.	Pálchuber, Péter: 1 article (07/2019)
5.	Simon, András: 1 article (07/2019)
6.	Varró, Gábor: 1 article (07/2019)
7.	Bloom, David: 1 article (11/2018)
8.	Chattopadhyay, Ansuman: 1 article (11/2018)
9.	Chowdari, Kodavali: 1 article (11/2018)
10.	D'Aiuto, Leonardo: 1 article (11/2018)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2019 - "A series of (±)-trans-dihydronarciclasine and (±)-trans-dihydrolycoricidine derivatives with variously substituted ring A was synthesised and evaluated for their antiproliferative activity against 60 human tumour cell lines (NCI60), representing leukemia, melanoma, and cancers of the lung, colon, brain, ovary, breast, prostate, as well as kidney in vitro. "
2.	Melanoma (Melanoma, Malignant) 07/01/2019 - "A series of (±)-trans-dihydronarciclasine and (±)-trans-dihydrolycoricidine derivatives with variously substituted ring A was synthesised and evaluated for their antiproliferative activity against 60 human tumour cell lines (NCI60), representing leukemia, melanoma, and cancers of the lung, colon, brain, ovary, breast, prostate, as well as kidney in vitro. "
3.	Leukemia 07/01/2019 - "A series of (±)-trans-dihydronarciclasine and (±)-trans-dihydrolycoricidine derivatives with variously substituted ring A was synthesised and evaluated for their antiproliferative activity against 60 human tumour cell lines (NCI60), representing leukemia, melanoma, and cancers of the lung, colon, brain, ovary, breast, prostate, as well as kidney in vitro. "
4.	Infections 11/09/2018 - "We have previously shown that trans-dihydrolycoricidine (R430), a lycorane-type alkaloid derivative, effectively inhibits HSV-1 infections in cultured cells. "

Related Drugs and Biologics

1.	Alkaloids
2.	lycorane
3.	dihydronarciclasine